First AD

Second AD

Genitourinary Cancers

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research. 

Evolving Treatment Paradigms for Renal Cell Carcinoma

Peer Exchange

Evolving Treatment Landscape of Renal Cell Carcinoma

Newly Diagnosed Metastatic Renal Cell Carcinoma

mRCC Patient Selection for Ipilimumab/Nivolumab

mRCC: Cytoreductive Nephrectomy in the Modern Era

Risk Stratification for Metastatic Renal Cell Carcinoma

Selecting Immunotherapy versus VEGF TKI for mRCC

Deferred Therapy for Favorable-Risk mRCC Patients

VEGF TKI + Immunotherapy Combinations for mRCC

Sunitinib 4/2 vs 2/1 Schedule for Patients with mRCC

Disease Progression in Patients with Metastatic RCC

Sequencing Approaches in Metastatic Renal Cell Carcinoma 

Considerations for Using Adjuvant Therapy in mRCC